Abstract
Metal complexes [Zn(II), Co(II), Ni(II), Mn(II) and Cu(II)] of sulfonamide 4-((4-chlorophenylsulfonamido)methyl)cyclohexanecarboxylic acid have been synthesized and characterized. The crystal structure of bis[4-[(4-Chloro-benzenesulfonylamino)-methyl]-cyclohexanecarboxylate cobalt (II). 4H2O (AZ-7) has been determined by X-ray crystallography showing square planar bipyramidal confirmation. Interaction studies of these compounds with DNA have been carried out through molecular docking studies, followed by nuclease activity using the agarose gel electrophoresis method. All the compounds have been found to cleave DNA. The interaction of these synthesized compounds with the DNA sequence of breast cancer suppressor gene 1 (BRCA1) has been studied using gel electrophoresis. For this study, two BRCA1 primers (B1E11A & B1E11B (exon11)) were selected and amplified through PCR reaction. After treatment with compounds, the expression analysis of BRCA 1 gene was also performed to quantify the expression relative fold-change (2−(∆∆CT)). The synthesized compounds were also evaluated for their antiglycation activity. The molecular docking study was carried out to support the experimental results. To further support this study, the antioxidant activity of these compounds was also performed. From all these studies, it has been proved that the Zn and Cu complexes were more effective and could be a potential source of cancer therapeutic agents.
Graphic abstract
Similar content being viewed by others
References
Akhtar A, Danish M, Asif A, Arshad MN, Asiri AM (2021) Docking assisted DNA-binding, biological screening, and nuclease activity of copper complexes derived from sulfonamides. J Coord Chem. https://doi.org/10.1080/00958972.2021.1931687
Alyar S, Şen C, Alyar H, Adem Ş, Kalkanci A, Ozdemir UO (2018) Synthesis, characterization, antimicrobial activity, carbonic anhydrase enzyme inhibitor effects, and computational studies on new Schiff bases of Sulfa drugs and their Pd (II), Cu (II) complexes. J Mol Struct 1171:214–222. https://doi.org/10.1016/j.molstruc.2018.06.004
Asif A, Zeeshan N, Mehmood S (2020) Antioxidant and antiglycation activities of traditional plants and identification of bioactive compounds from extracts of Hordeum vulgare by LC–MS and GC–MS. J Food Biochem 44:e13381. https://doi.org/10.1111/jfbc.13381
Balmain A, Gray J, Ponder B (2003) The genetics and genomics of cancer. Nat Genet 33:238–244. https://doi.org/10.1038/ng1107
Beckmann M, Niederacher D, Schnürch H-G, Gusterson BA, Bender HG (1997) Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med 75:429–439. https://doi.org/10.1007/s001090050128
Berman H, Henrick K, Nakamura H, Markley JL (2007) The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data. Nucleic Acids Res 35:D301–D303. https://doi.org/10.1093/nar/gkl971
Bienstock RJ, Darden T, Wiseman R, Pedersen L, Barrett JC (1996) Molecular modeling of the amino-terminal zinc ring domain of BRCA1. Cancer Res 56:2539–2545. https://pubmed.ncbi.nlm.nih.gov/8653694/
Bogen SL, Arasappan A, Velazquez F et al (2010) Discovery of potent sulfonamide P4-capped ketoamide second generation inhibitors of hepatitis C virus NS3 serine protease with favorable pharmacokinetic profiles in preclinical species. Bioorg Med Chem 18:1854–1865. https://doi.org/10.1016/j.bmc.2010.01.044
Burnett MN, Johnson CK (1996) ORTEP-III: Oak Ridge thermal ellipsoid plot program for crystal structure illustrations. Citeseer. https://doi.org/10.2172/369685
Carta F, Scozzafava A, Supuran CT (2012) Sulfonamides: a patent review (2008–2012). Expert Opin Ther Pat 22:747–758. https://doi.org/10.1517/13543776.2012.698264
Cheng X-C, Wang Q, Fang H, Xu W-F (2008) Role of sulfonamide group in matrix metalloproteinase inhibitors. Curr Med Chem 15:368–373. https://doi.org/10.2174/092986708783497300
Danish M, Butt RA, Tahir MN, Ashfaq M, Hafeez ST, Ahmed MN, Qureshi H (2017) 4-((4-Chlorophenylsulfonamido) methyl) cyclohexanecarboxylic Acid: Synthesis, Crystal Structure and Biological Activities. 结构化学 8. doi: https://doi.org/10.14102/j.cnki.0254-5861.2011-1497
Danish M, Raza MA, Khalid H, Iftikhar U, Arshad MN (2021) New metal complexes of sulfonamide: Synthesis, characterization, in-vitro anticancer, anticholinesterase, antioxidant, and antibacterial studies. Appl Organomet Chem. https://doi.org/10.1002/aoc.6033
Deng C-X, Scott F (2000) Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation. Oncogene 19:1059–1064. https://doi.org/10.1038/sj.onc.1203269
El-Bahr SM (2013) Biochemistry of free radicals and oxidative stress. Biochemistry 1:11–11. https://doi.org/10.5567/sciintl.2013.111.117
Farrugia LJ (2012) WinGX and ORTEP for Windows: an update. J Appl Crystallogr 45:849–854. https://doi.org/10.1107/S0021889812029111
Feig DI, Reid TM, Loeb LA (1994) Reactive oxygen species in tumorigenesis. Cancer Res 54:1890s–1894s. https://pubmed.ncbi.nlm.nih.gov/8137306/
Foner S (1964) Free radicals and unstable molecules. Science 143:441–450. https://www.jstor.org/stable/1712032
Ford D, Easton DF, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801430/
Ford D, Easton D, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676–689. https://doi.org/10.1086/301749
Fricker SP (2007) Metal based drugs: from serendipity to design. Dalton Trans. https://doi.org/10.1039/b705551j
Gorodetska I, Kozeretska I, Dubrovska A (2019) BRCA genes: the role in genome stability, cancer stemness and therapy resistance. J Cancer 10:2109. https://doi.org/10.7150/jca.30410
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King M-C (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684–1689. https://doi.org/10.1126/science.2270482
Kachaeva MV, Hodyna DM, Semenyuta IV et al (2018) Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents. Comput Biol Chem 74:294–303. https://doi.org/10.1016/j.compbiolchem.2018.04.006
Kostova I (2006) Ruthenium complexes as anticancer agents. Curr Med Chem 13:1085–1107. https://doi.org/10.2174/092986706776360941
Lepre C, Lippard S (1990) Interaction of platinum antitumor compounds with DNA. In: Nucleic acids and molecular biology, vol 4. Springer, pp 9–38. doi:https://doi.org/10.1007/978-3-642-84150-7-2
Manzoor S, Petreni A, Raza MK, Supuran CT, Hoda N (2021) Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: Design, synthesis, computational and enzyme inhibition studies. Bioorg Med Chem Lett 48:128249. https://doi.org/10.1016/j.bmcl.2021.128249
Martins N, Santos N, Curti C, Bianchi M, Santos A (2008) Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J Appl Toxicol 28:337–344. https://doi.org/10.1002/jat.1284
Miki Y, Swensen J, Shattuck-Eidens D et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71. https://www.jstor.org/stable/2884716
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chen 30:2785–2791. https://doi.org/10.1002/jcc.21256
Noda N, Wakasugi H (2001) Cancer and oxidative stress. Jpn Med Assoc J 44:535–539
Osborne C, Wilson P, Tripathy D (2004) Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist 9:361–377. https://doi.org/10.1634/theoncologist.9-4-361
Park H, Boyington JC (2010) The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding. J Biol Chem 285:40762–40770. https://doi.org/10.1074/jbc.M110.169276
Pellei M, Del Bello F, Porchia M, Santini C (2021) Zinc coordination complexes as anticancer agents. Coord Chem Rev 445:214088. https://doi.org/10.1016/j.ccr.2021.214088
Phillips K-A (2000) Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers. Am J Clin Oncol 18:107S-112S. http://intl.jco.org/cgi/content/abstract/18/21/107S
Rahman N, Stratton MR (1998) The genetics of breast cancer susceptibility. Annu Rev Genet 32:95. https://doi.org/10.1146/annurev.genet.32.1.95
Ratanaphan A, Canyuk B, Wasiksiri S, Mahasawat P (2005) In vitro platination of human breast cancer suppressor gene1 (BRCA1) by the anticancer drug carboplatin. Biochim Biophys Acta Gen Subj 1725:145–151. https://doi.org/10.1016/j.bbagen.2005.07.006
Ratanaphan A, Temboot P, Dyson PJ (2010) In vitro Ruthenation of Human Breast Cancer Suppressor Gene 1 (BRCA1) by the Antimetastasis Compound RAPTA-C and Its Analogue CarboRAPTA-C. Chem Biodivers 7:1290–1302. https://doi.org/10.1002/cbdv.200900288
Reddy PR, Shilpa A (2011) Oxidative and hydrolytic DNA cleavage by Cu (II) complexes of salicylidene tyrosine schiff base and 1, 10 phenanthroline/bipyridine. Polyhedron 30:565–572. https://doi.org/10.1016/j.poly.2010.11.015
Reedijk J (1996) Improved understanding in platinium antitumour chemistry. Chem Commun, pp 801–806. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937549/
Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185–187. https://doi.org/10.1038/ng1096-185
Rosen EM, Fan S, Pestell RG, Goldberg ID (2003) BRCA1 gene in breast cancer. J Cell Physiol 196:19–41. https://doi.org/10.1002/jcp.10257
Sambrook H (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor, New York.
Schumacker PT (2006) Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10:175–176. https://doi.org/10.1016/j.ccr.2006.08.015
Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM (1997) Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90:425–435. https://doi.org/10.1016/S0092-8674(00)80503-6
Sharma R, Soman SS (2015) Design and synthesis of sulfonamide derivatives of pyrrolidine and piperidine as anti-diabetic agents. Eur J Med Chem 90:342–350. https://doi.org/10.1016/j.ejmech.2014.11.041
Sheldrick GM (2014) SHELXT: Integrating space group determination and structure solution. Acta Crystallogr A Found Adv 70:C1437. https://doi.org/10.1107/S2053273314026370
Shoaib Ahmad Shah S, Rivera G, Ashfaq M (2013) Recent advances in medicinal chemistry of sulfonamides. Rational design as anti-tumoral, anti-bacterial and anti-inflammatory agents. Mini Rev Med Chem 13:70–86. https://pubmed.ncbi.nlm.nih.gov/22625411/
Sobol H, Stoppa-Lyonnet D, Bressac-de-Paillerets B et al. (1996) Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Cancer Res 56:3216–3219. https://pubmed.ncbi.nlm.nih.gov/8764110/
Spek AL (2015) PLATON SQUEEZE: a tool for the calculation of the disordered solvent contribution to the calculated structure factors. Acta Crystallogr C Struct Chem 71:9–18. https://doi.org/10.1107/S2053229614024929
Supuran CT (2017) Sulfonamides. Multidisciplinary Digital Publishing Institute. https://doi.org/10.3390/molecules22101642
Vermeulen K, Van Bockstaele DR, Berneman ZN (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36:131–149. https://doi.org/10.1046/j.1365-2184.2003.00266.x
Vieira LMM, de Almeida MV, Lourenço MCS, Bezerra FAF, Fontes APS (2009) Synthesis and antitubercular activity of palladium and platinum complexes with fluoroquinolones. Eur J Med Chem 44:4107–4111. https://doi.org/10.1016/j.ejmech.2009.05.001
Acknowledgements
We are thankful to Dr. Awais Asif, Nawaz Shareef Medical College, University of Gujrat, Pakistan, for providing gene interaction and antiglycation facilities. We are thankful to the Higher Education Commission (HEC) of Pakistan for funding this work under Project No. 20-2549/NRPU/R&D/HEC/12. AA thanks the Higher Education Commission (HEC) for the award of Indigenous Ph.D. Fellowship Pin No. 518-107661-2PS5-078(50043471).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Akhtar, A., Danish, M. Newly synthesized metal complexes of sulfonamides: DNA cleavage, BRCA1 gene interaction, expression analysis, antioxidant and antiglycation studies. Chem. Pap. 76, 515–532 (2022). https://doi.org/10.1007/s11696-021-01878-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11696-021-01878-3